CAS 161735-79-1: Rasagiline mesylate

Description: Rasagiline mesylate is a selective, irreversible monoamine oxidase B (MAO-B) inhibitor primarily used in the treatment of Parkinson's disease. It is characterized by its ability to increase dopamine levels in the brain, thereby alleviating symptoms associated with this neurodegenerative disorder. The substance appears as a white to off-white crystalline powder and is soluble in water and organic solvents, which facilitates its formulation in various pharmaceutical preparations. Rasagiline mesylate has a molecular formula that reflects its complex structure, incorporating both a rasagiline base and a mesylate group, which enhances its stability and bioavailability. The compound is typically administered orally and is known for its favorable pharmacokinetic profile, including a long half-life that allows for once-daily dosing. Additionally, it has a low potential for drug-drug interactions, making it a preferred choice in combination therapies for Parkinson's disease. As with any medication, it is essential to monitor for potential side effects and contraindications during treatment.

Formula: C₁₃H₁₇NO₃S

InChI: InChI=1/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1

Synonyms:

• (1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate (1:1)
• (1R)-N-(Prop-2-yn-1-yl)indan-1-amine methanesulfonate (1:1)
• 1H-inden-1-amine, 2,3-dihydro-N-2-propyn-1-yl-, (1R)-, methanesulfonate (1:1)
• 1H-inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-, methanesulfonate (1:1)
• acide méthanesulfonique - (1R)-N-prop-2-yn-1-yl-2,3-dihydro-1H-indén-1-amine (1:1)
• Methansulfons?ure--(1R)-N-prop-2-in-1-yl-2,3-dihydro-1H-inden-1-amin(1:1)
• (1R)-N-prop-2-yn-1-yl-2,3-dihydro-1H-inden-1-amine methanesulfonate

1H-Inden-1-amine, 2,3-dihydro-N-2-propyn-1-yl-, (1R)-, methanesulfonate (1:1)

CAS: 161735-79-1

• Formula: C₁₃H₁₇NO₃S
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 267.34398000000004

Rasagiline Mesylate

CAS: 161735-79-1

• Formula: C₁₂H₁₃N·CH₄O₃S
• Color and Shape: White To Off-White Solid
• Molecular weight: 171.24 96.10

Rasagiline mesylate

CAS: 161735-79-1

• Molecular weight: 267.34g/mol

Rasagiline mesylate

CAS: 161735-79-1

• Formula: C₁₂H₁₃N·CH₄O₃S
• Molecular weight: 267.34

Rasagiline Mesylate

CAS: 161735-79-1

• Purity: ≥98%
• Molecular weight: 267.34g/mol

Rasagiline Mesilate

CAS: 161735-79-1

• Formula: C₁₂H₁₃N·CH₄O₃S
• Color and Shape: Neat
• Molecular weight: 267.34

Rasagiline Mesylate

CAS: 161735-79-1

• Formula: C₁₂H₁₃N·CH₄O₃S
• Purity: >98.0%(HPLC)
• Color and Shape: White to Almost white powder to crystal
• Molecular weight: 267.34

Rasagiline Mesylate

CAS: 161735-79-1

Rasagiline Mesylate (AGN1135) is a novel MAO-B inhibitor, which can treat idiopathic Parkinson's disease.

• Formula: C₁₃H₁₇NO₃S
• Purity: 99.33%
• Color and Shape: White Powder
• Molecular weight: 267.34

Rasagiline Mesylate

CAS: 161735-79-1

Applications Rasagiline is a selective irreversible MAO-B inhibitor (1,2,3,4). Rasagiline is an Antiparkinsonian agent. References …

• Formula: C₁₂H₁₃N·CH₄O₃S
• Color and Shape: White
• Molecular weight: 267.34

Rasagiline mesylate

CAS: 161735-79-1

Monoamine oxidase-B inhibitor; anti-parkinsonian; neuroprotective

• Formula: C₁₂H₁₃N•CH₄O₃S
• Purity: Min. 95%
• Color and Shape: Powder
• Molecular weight: 267.35 g/mol